National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health · Grant
Overview
Supports investigator-led phase 0, I or II clinical trials of cancer diagnostic or therapeutic interventions within participating NCI programme interests. Phase III trials are excluded.
Funding amount
Up to USD 499999 in direct costs per year
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 5 October 2026. Next renewal/resubmission/revision deadline, where permitted: 5 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2027. This is separate from the application deadline.
Contact
National Institutes of Health · [email protected]
Keywords
Health sciences